Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAK | O14976 | 5/20 | 0.65 |
| ▸ | APP | P05067 | 2/20 | 0.60 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.60 |
| ▸ | FADS1 | O60427 | 1/20 | 0.59 |
| ▸ | MAPT | P10636 | 2/20 | 0.57 |
| ▸ | GAA | P10253 | 1/20 | 0.57 |
| ▸ | ATM | Q13315 | 1/20 | 0.57 |
| ▸ | POLB | P06746 | 1/20 | 0.57 |
| ▸ | THRB | P10828 | 1/20 | 0.57 |
| ▸ | RIPK2 | O43353 | 2/20 | 0.56 |
| ▸ | COQ8A | Q8NI60 | 2/20 | 0.56 |
| ▸ | NLK | Q9UBE8 | 2/20 | 0.56 |
| ▸ | EGFR | P00533 | 2/20 | 0.53 |
| ▸ | ERBB3 | P21860 | 1/20 | 0.53 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.53 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.53 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.52 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19633676 | 0.90 | GAK (0.68) | GAKRIPK2COQ8ANLKEGFR | |
| SCHEMBL30420470 | 0.88 | GAK (0.67) | GAKRIPK2COQ8ANLKEGFR | |
| Metaquine SCHEMBL7205743 | 0.87 | FADS1 (0.71) | GAKAPPNR4A2FADS1MAPT | |
| SCHEMBL19633647 | 0.86 | GAK (0.66) | GAKRIPK2COQ8ANLKEGFR | |
| SCHEMBL23706787 | 0.86 | GAK (0.61) | GAKMAPTRIPK2COQ8ANLK | |
| SCHEMBL21121632 | 0.86 | MAPT (0.69) | GAKAPPNR4A2MAPTGAA | |
| SCHEMBL21121679 | 0.85 | HTT (0.64) | GAKRIPK2COQ8ANLKEGFR | |
| SCHEMBL19633799 | 0.85 | GAK (0.60) | GAKMAPTGAAATMRIPK2 | |
| SCHEMBL21121509 | 0.85 | HTT (0.64) | GAKRIPK2COQ8ANLKEGFR | |
| SCHEMBL30420414 | 0.85 | HTT (0.64) | GAKRIPK2COQ8ANLKEGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3481806-B1 | 4-ANILINO-QUINOLINE COMPOUNDS AS ANTI-CANCER AGENTS | INST NAT SANTE RECH MED (FR) | 2023-06-07 | — | — | EP | claimed |
| EP-3735407-A1 | SUBSTITUTED HALO-QUINOLINE DERIVATES FOR USE IN THE TREATMENT OF LYMPHOMAS AND LEUKEMIA | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE - INSERM (FR) | 2020-11-11 | — | — | EP | claimed |
| WO-2019134969-A1 | SUBSTITUTED HALO-QUINOLINE DERIVATES FOR USE IN THE TREATMENT OF LYMPHOMAS AND LEUKEMIA | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 2019-07-11 | — | — | WO | claimed |
| EP-3735407-A1 | SUBSTITUTED HALO-QUINOLINE DERIVATES FOR USE IN THE TREATMENT OF LYMPHOMAS AND LEUKEMIA | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE - INSERM (FR) | 2020-11-11 | — | — | EP | disclosed |
| WO-2019173482-A1 | 4-AMINOQUINOLINE COMPOUNDS FOR THE TREATMENT OF ANGIOGENESIS | Sanford Burnham Prebys Medical Discovery Institute (US) | 2019-09-12 | — | — | WO | disclosed |
| WO-2019134969-A1 | SUBSTITUTED HALO-QUINOLINE DERIVATES FOR USE IN THE TREATMENT OF LYMPHOMAS AND LEUKEMIA | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 2019-07-11 | — | — | WO | disclosed |
| WO-2017198196-A1 | QUINOLINE DERIVATIVE HAVING ANTI-TUMOR ACTIVITY | 王子厚 | 2017-11-23 | — | — | WO | disclosed |